Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects
Abstract Vutiglabridin, which affects the pharmacokinetics (PKs) of food, is currently under clinical development for the treatment of obesity. This study aimed to evaluate the effects of low‐ and high‐fat meals on PKs of vutiglabridin in healthy male subjects. A randomized, open‐label, single‐dose,...
Saved in:
Main Authors: | Heejae Won (Author), Deok Yong Yoon (Author), Sangmi Lee (Author), Joo‐Youn Cho (Author), Jaeseong Oh (Author), In‐Jin Jang (Author), Sang‐Ku Yoo (Author), Kyung‐Sang Yu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study
by: Joo Young Na, et al.
Published: (2022) -
Vutiglabridin Alleviates Cellular Senescence with Metabolic Regulation and Circadian Clock in Human Dermal Fibroblasts
by: Jin-Woong Heo, et al.
Published: (2024) -
Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects
by: Inyoung Hwang, et al.
Published: (2022) -
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects
by: Sejung Hwang, et al.
Published: (2022) -
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects
by: Xu Jiang, et al.
Published: (2024)